ATRA vs K · rev $128.9M vs P/E 23, $29.03B cap
Atara Biotherapeutics Inc (ATRA) versus Kellanova (K) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Kellanova (K) is a packaged foods company listed on US.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
K does not have a complete income-statement cache yet.
ATRA currently screens at market cap $87.1M. K currently screens at market cap $29.03B and trailing P/E 22.8.
Not investment advice. Open the ATRA and K stock pages for the full models.
Not investment advice.